Increased Risk of Myocardial Infarction with Dabigatran Etexilate: Fact or Fiction? A Critical Meta-analysis from Integrating Randomized Controlled Trials and Real-world Studies: Wine or Spritzer?
Overview
Overview
Journal
Int J Cardiol
Publisher
Elsevier
Specialty
Cardiology & Vascular Diseases
Date
2018 Sep 17
PMID
30219540
Citations
3
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Grajek S, Kaluzna-Oleksy M, Siller-Matula J, Grajek M, Michalak M J Pers Med. 2021; 11(10).
PMID: 34683155 PMC: 8539187. DOI: 10.3390/jpm11101013.
Safety of Dabigatran as an Anticoagulant: A Systematic Review and Meta-Analysis.
Zhou Y, Yao Z, Zhu L, Tang Y, Chen J, Wu J Front Pharmacol. 2021; 12:626063.
PMID: 33633574 PMC: 7901998. DOI: 10.3389/fphar.2021.626063.
Yan Y, Ding Z, Pan M, Xia Q, Cui J, Wang L Front Cardiovasc Med. 2020; 7:586020.
PMID: 33304929 PMC: 7693545. DOI: 10.3389/fcvm.2020.586020.